NCT02325921View on ClinicalTrials.gov

MRI in Renal Tumors

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Renal Cell Carcinoma
Interventions
DEVICE

Magnetic Resonance Imaging

One MRI examination, diagnostic scanning protocol as used for renal tumours with additional diffusion weighted sequences, but without contrast enhancement.

Trial Locations (1)

6500HB

Radboud University Medical Center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02325921 - MRI in Renal Tumors | Biotech Hunter | Biotech Hunter